Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model

OMICS A Journal of Integrative Biology

Volumn 8, Issue 4, 2004, Pages 267-288

  Davidov, Eugene ^a   Clish, Clary B ^a   Oresic, Matej ^a   Meys, Michael ^a   Stochaj, Wayne ^a   Snell, Philip ^a   Lavine, Gary ^a   Londo, Thomas R ^a   Adourian, Aram ^a   Zhang, Xiang ^a   Johnston, Mark ^a   Morel, Nicole ^a   Marple, Edward W ^a   Plasterer, Thomas N ^a   Neumann, Eric ^a   Verheij, Elwin ^b   Vogels, Jack T W E ^b   Havekes, Louis M ^b,c   Van Der Greef, Jan ^a,b,c   Naylor, Stephen ^a,d  

^a Waltham MA 02451 USA   (United States)

^b TNO   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Leiden University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E3; LIPID; PROTEIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA MODIFICATION; GENE MUTATION; INFORMATION PROCESSING; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; METABOLITE; MOUSE; MULTIVARIATE ANALYSIS; NONHUMAN; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE;

EID: 20844437901     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2004.8.267     Document Type: Article

References (58)

1. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res 35, 2294-2304.
2. ALTSHULER, D., DALY, M., and KRUGLYAK, L. (2000). Guilt by association. Nat Genet 26, 135-137.
3. BUTTE, A.J., TAMAYO, P., SLONIM, D., et al. (2000). Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci USA 97, 12182-12186.
4. CALLOW, M.J., DUDOIT, S., GONG, E.L., et al. (2000). Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res 10, 2022-2029.
5. CLISH, C., DAVIDOV, E., ORESIC, M., et al. (2004). Integrative biological analysis of the APOE*3 transgenic mouse. OMICS J Integr Biol 2004 8, 3-13.
6. COIFMAN, R.R., and WICKERHAUSER, M.V. (1996). Wavelets, adapted waveforms and de-noising. Electroencephalogr Clin Neurophysiol Suppl 45, 57-78.
7. DAVIDOV, E.J., HOLLAND, J., MARPLE, E.W., et al. (2003). Advancing drug discovery through systems biology. Drug Discovery Today 8, 175-183.
8. DAVIDSON, E.H., RAST, J.P., OLIVERI, P., et al. (2002). A genomic regulatory network for development. Science 295, 1669-1678.
9. DAYKIN, C.A., CORCORAN, D., HANSEN, S.H. et al. (2001). Application of directly coupled HPLC NMR to separation and characterization of lipoproteins from human serum. Anal Chem 73, 1084-1090.
10. FIEHN, O., KOPKA, J., TRETHEWEY, R.N., et al. (2000). Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Anal Chem 72, 3573-3580.
11. FIEHN, O., KOPKA, J., DORMANN, P., et al. (2000). Metabolite profiling for plant functional genomics. Nat Biotechnoll 18, 1157-1161.
12. GASPARI, M., WULFERT, F., TAS, A.C., et al. (2001). Novel strategies in mass spectrometric data handling. Adv Mass Spectrom 15, 283-296.
13. GLASS, C.K., and WITZTUM, J.L. (2001). Atherosclerosis, the road ahead. Cell 104, 503-516.
14. GYGI, S.P., RIST, B., GERBER, S.A., et al. (1999). Quantitative analysis of complex protein mixtures using isotopecoded affinity tags. Nat Biotechnol 17, 994-999.
15. HARTEMINK, A.J., GIFFORD, D.K., JAAKKOLA, T.S., et al. (2001). Using graphical models and genomic expression data to statistically validate models of genetic regulatory networks. Pacific Symp Biocomput 422-433.
16. HAVEKES, L., DE WIT, E., LEUVEN, J.G., et al. (1986). Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia. Hum Genet 73, 157-163.
17. 1H NMR data from human blood plasma. J Magn Reson B 106, 191-194.
18. HOOD, L. (2002). A personal view of molecular technology and how it has changed biology. J Protome Res 1, 399-409.
19. HOOD, L. (2003). Systems biology: integrating technology, biology and computation. Mech Ageing Dev 124, 9-16.
20. IDEKER, T., GALITSKI, T., and HOOD, L. (2001a). A new approach to decoding life: systems biology. Annu Rev Genomics Hum Genet 2, 343-372.
21. IDEKER, T., THORSSON, V., RANISH, J.A., et al. (2001b). Integrated genomic and proteomic analysis of a systematically perturbed metabolic network. Science 292, 929-934.
22. JONG, M.C., DAHLMANS, V.E., VAN GORP, P.J., et al. (1996a). Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3 Leiden and human apolipoprotein C1. Arterioscler Thromb Vasc Biol 16, 934-940.
23. JONG, M.C., DAHLMANNS, V.E., VAN GORP, P.J., et al. (1996b). In the absence of low density lipoprotein receptor, apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway. J Clin Invest 98, 2259-2267.
24. KITAMURA, T., and SASAKI, H. (1996). Quantative analysis of serum lipoproteins (CM, VLDL, LDL, and HDL) by high-performance gel filtration chromatography. Chromatography 17, 33-37.
25. KITANO, H. (2001). Foundations of Systems Biology (MIT Press, Cambridge, MA).
26. KITANO, H. (2002a). Systems biology: a brief overview. Science 295, 1662-1664.
27. KITANO, H. (2002b). Computational systems biology. Nature 420, 206-210.
28. KULSCHAR, R., ENGELMAAN, B., BRAUTIGAM, C., et al. (1995). Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis. Eur J Clin Invest 25, 258-265.
29. LUTGENS, E., DAEMEN, M., KOCKS, M., et al. (1999). Atherosclerosis in APOE*3-Leiden transgenic mice. From proliferative to atheromatous stage. Circulation 99, 276-283.
30. MENSENKAMP, A.R., JONG, M.C., VAN GOOR, H., et al. (1999). Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. J Biol Chem 274, 35711-35718.
31. MENSENKAMP, A.R., VAN LUYN, M.J., VAN GOOR, H., et al. (2000). Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoproein E3-Leiden transgenic mice. J Hepatol 33, 189-198.
32. MOGHADASIAN, M.H., McMANUS, B.M., NGUYEN, L.B., et al. (2001). Pathophysiology of apolipoprotein E deficiency in mice: relevance to apo E-related disorders in humans. FASEB J 15, 2623-2630.
33. MOREL, N.M., HOLLAND, J.M., VAN DER GREEF, J., et al. (2004). Introduction to systems biology: a new approach to understanding disease and treatment. Mayo Clin Proc 79, 65-658.
34. MURPHY, A.A., SANTANAM, N., MORALES, A.J., et al. (1998). Lysophosphatidyl choline, a chemotactic factor for monocytes/T-lymphocytes is elevated in endometriosis. J Clin Endocrinol Metabol 83, 2110-2113.
35. NEUMANN, E., and THOMAS, J. (2002). Knowledge assembly for the life sciences. Drug Discovery Today 7, S160-S162.
36. NICHOLSON, J.K., LINDON, J.C., and HOLMES, E. (1999). "Metabonomics": Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariage statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189.
37. NICHOLSON, J.K., and WILSON, I.D. (2003). Opinion: Understanding global systems biology, metabonomics, and the continuum of metabolism. Nat Rev Drug Discov 2, 668-676.
38. NILSSON, J., DAHLGREN, B., ARES, M, et al. (1998). Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor. Arterioscler Thromb Vasc Biol 18, 13-19.
39. NOFER, J.R., LEVKAU, B., WOLINSKA, L, et al. (2001). Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids J Biol Chem 276, 34480-34485.
40. OLIVER, S. (2000). Guilt-by-association goes global. Nature 403, 601-603.
41. PACKARD, C.J., O'REILLY, D.S., CASLAKE, M.J., et al. (2000). Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. N Engl J Med 343, 1179-1182.
42. PARK, Z.-Y., and RUSSELL, D.H. (2000). Thermal denaturation: a useful technique in peptide mass mapping. Anal Chem 72, 2667-2670.
43. RAAMSDONK, L.M., TEUSINK, B., BROADHURST, D. et al. (2001). A fuctional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations. Nat Biotechnol 19, 45-50.
44. SMOLA, A.J., SCHOLKOPF, B., and MULLER, K.-R. (1998). The connection between regulation operators and support vector kernels. Neural Networks 10, 637-649.
45. STOLL, M., COWLEY, A.W., TONELLATO, P.J., et al. (2001). A genomic-systems biology map for cardiovascular function. Science 294, 1723-1726.
46. VAN DER GREEF, J., DAVIDOV, E., VERHEIJ, E., et al. (2003). The role of metabolism in systems biology. In Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis. G.G. Harrigan and R. Goodacre, eds. (Kluwer Academic Press, Boston), pgs. 171-198.
47. VAN DEN MAAGDENBERG, A.M., DE KNIJFF, P., STALENHOEF, A.F., et al. (1989). Apolipoprotein E*3-Leiden allele results from a partial gene duplication in exon 4. Biochem Biophys Res Commun 165, 851-857.
48. VAN DEN MAAGDENBERG, A.M., HOFKER, M.H., KRIMPENFORT, P.J., et al. (1993). Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem 268, 10540-10545.
49. VAN DIJK, K.W., VAN VLIJMEN, B.J., DE WINTHER, M.P., et al. (1999). Hyperlipidemia of ApoE2 (Arg158-Cys) and ApoE3-Leiden transgenic mice is modulated predominantly by LDL receptor expression. Arterioscler Thromb Vasc Biol 19, 2945-2951.
50. VAN VLIJMEN, B.J., VAN DEN MAAGDENBERG, A.M., GIJBELS, M.J., et al. (1994). Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J Clin Invest 93, 1403-1410.
51. VAN VLIJMEN, B.J.M., VAN'T HOF, H.B., MOL, M.J., et al. (1996). Modulation of very low density lipoprotein production and clearance contributes to age- and gender-dependent hyperlipoproteinemia in apolipoprotein E3-Leiden Transgenic Mice. Am Soc Clin Invest 97, 1184-1192.
52. VOGELS, J.T., VENEKAMP, A.C.T., and VAN DER GREEF, J. (1996). Partial linear fit: a new NMR spectroscopy preprocessing tool for pattern recognition applications. J Chemometrics 10, 425-438.
53. WANG, N., ARAI, T., JI, Y., et al. (1998). Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem 273, 32920-32926.
54. WILLIAMSON, R., LEE, D., HAGAMAN, J., et al. (1992). Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I. Proc Natl Acad Sci U S A 89, 7134-7138.
55. WINDIG, W., and MEUZELAAR, H.L. (1984). Nonsupervised numerical component extraction from pyrolysis mass spectra of complex mixtures. Anal Chem 56, 2297-2303.
56. WINDIG, W., PHALP, J.M., and PAYNE, A.W. (1996). A noise and background reduction method for component detection in liquid chromatography/mass spectrometry. Anal Chem 68, 3602-3606.
57. YATES, J.R., LINK, A.J., and SCHIELTZ, D. (2000). Direct analysis of proteins in mixtures. Application to protein complexes Methods Mol Biol 146, 17-26.
58. YOSHINO, H., and MINARI, O. (1980). Effect of lysolecithin on the binding of 1-anilino-8-naphthalene sulfonate to apoHDL, apoA-I or apoA-II from human serum high density lipoprotein. J Biochem (Tokyo) 87, 1357-1383.